CDT insider trading
NasdaqCM HealthcareCDT Equity Inc.: insider trade history from SEC Form 4 filings.
About CDT Equity Inc.
CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
Company website: www.conduitpharma.com
CDT insider activity at a glance
FilingIQ tracks 52 insider transactions for CDT in filings since Sep 26, 2023. The most recent transaction is dated Aug 28, 2026.
Across the full history, 0 open-market purchases
and 21 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on CDT insider trades is 54.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest CDT Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading CDT
Frequently asked
- How many insider trades does FilingIQ track for CDT?
- FilingIQ tracks 52 Form 4 insider transactions for CDT (CDT Equity Inc.), covering filings from Sep 26, 2023 onwards. 2 of those are dated within the last 90 days.
- Are CDT insiders net buyers or net sellers?
- Across the full Form 4 history for CDT, 0 transactions (0%) were open-market purchases and 21 (40%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CDT insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is CDT in?
- CDT Equity Inc. (CDT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.86M.
Methodology & sources
Every CDT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.